Added to YB: 2025-07-28
Pitch date: 2025-07-25
COV.V [neutral]
Covalon Technologies Ltd.
-27.89%
current return
Author Info
Stocks & Stones manages the Rivemont MicroCap Fund, which has several million $ in assets. I’m here to help you avoid the pitfalls of microcap investing. Sign up for the newsletter.
Company Info
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
Market Cap
CAD 65.8M
Pitch Price
CAD 2.45
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.34
P/E
27.87
EV/Sales
1.48
Sector
Biotechnology
Category
turnaround
Three Stocks I'll Watch Closely in August - Covalon Technologies (TSX-V: COV)
COV.V (watchlist): Med device co in wound care & vascular access. New CEO turnaround showing 21% YoY revenue & 57% YoY Adj EBITDA growth H1 2025 despite sequential decline. Management forecasts 'strong Q3' ahead. At $2.62, trades at 11.8x P/E, 7.9x EV/EBITDA, 1.6x EV/Rev. Comps acquired at 3-7x revenue.
Read full article (2 min)